Issue 000 | U.S. Pilot | US

NXTC

NextCure, Inc.

Passing Verified 10-Q | 2026-05-07 Filing currency: USD
Margin of Safety 66.9%

GNNI internal calculation. Market context inputs are retained internally and are not displayed.

Current Assets
31,741,000USD
Total Liabilities
11,261,000USD
NCAV
20,480,000USD
Cash
15,167,000USD
NCAV per share
5.68USD/share
Evidence
7 annual | 20 quarterly

Business Profile

Checklist-driven facts extracted from filing text. Missing fields stay visible.

Business profile not generated.

Run python -m application.cli.business_profile run --market US --one NXTC, then regenerate the site.

Known Unknowns

Medium | Share Count

Issue 000 does not yet evaluate share count trend or post-filing dilution beyond Mary's screening flags.

Low | Classification

U.S. Pilot rows are surfaced for source inspection and may still need manual business classification review.

Annual Financials

Latest annual periods, newest first. Missing cells render as n/a.

Metric
2025-12-31
10-K
USD
2024-12-31
10-K
USD
2023-12-31
10-K
USD
2022-12-31
10-K
USD
2021-12-31
10-K
USD
2020-12-31
10-K
USD
2019-12-31
10-K
USD
Revenue n/a n/a n/a n/a n/a 22,378,000 6,347,000
Operating Income -57,616,000 -59,748,000 -67,637,000 -75,909,000 -70,765,000 -41,225,000 -37,482,000
Net Income -55,844,000 -55,654,000 -62,723,000 -74,733,000 -69,389,000 -36,603,000 -33,737,000
Cash From Operations -49,613,000 -40,805,000 -52,974,000 -53,886,000 -57,244,000 -44,954,000 -35,623,000
Capex n/a -474,000 -820,000 -2,116,000 -2,360,000 -7,132,000 -3,371,000
Free Cash Flow n/a -41,279,000 -53,794,000 -56,002,000 -59,604,000 -52,086,000 -38,994,000
Cash And Equivalents 25,982,000 27,727,000 13,082,000 26,630,000 12,337,000 32,772,000 34,091,000
Accounts Receivable n/a n/a n/a n/a n/a n/a n/a
Inventory n/a n/a n/a n/a n/a n/a n/a
Total Current Assets 43,747,000 71,807,000 112,725,000 163,983,000 227,817,000 287,978,000 339,995,000
Total Assets 50,183,000 80,860,000 128,038,000 184,161,000 242,386,000 306,644,000 356,168,000
Total Current Liabilities 10,566,000 9,574,000 6,883,000 9,127,000 6,608,000 10,325,000 15,042,000
Total Liabilities 15,240,000 15,388,000 13,617,000 16,631,000 9,000,000 12,923,000 34,684,000
Shareholders Equity 34,943,000 65,472,000 114,421,000 167,530,000 233,386,000 293,721,000 321,484,000
Shares Outstanding 3,505,621 28,006,684 27,903,027 27,774,536 27,680,997 27,568,802 27,499,260
Shares Outstanding Diluted n/a n/a n/a n/a n/a n/a n/a
Weighted Avg Shares Diluted 2,842,448 27,964,639 27,836,584 27,744,209 27,615,977 27,532,177 n/a
Weighted Avg Shares Basic 2,842,448 27,964,639 27,836,584 27,744,209 27,615,977 27,532,177 n/a
Quarterly Financials

Latest quarterly periods, newest first. Periods are shown only when Data Vault has them.

Metric
2026-03-31
10-Q
USD
2025-12-31
10-K
USD
2025-09-30
10-Q
USD
2025-06-30
10-Q
USD
2025-03-31
10-Q
USD
2024-12-31
10-K
USD
2024-09-30
10-Q
USD
2024-06-30
10-Q
USD
2024-03-31
10-Q
USD
2023-12-31
10-K
USD
2023-09-30
10-Q
USD
2023-06-30
10-Q
USD
2023-03-31
10-Q
USD
2022-12-31
10-K
USD
2022-09-30
10-Q
USD
2022-06-30
10-Q
USD
2022-03-31
10-Q
USD
2021-12-31
10-K
USD
2021-09-30
10-Q
USD
2021-06-30
10-Q
USD
Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income -10,105,000 -9,757,000 -8,945,000 -27,292,000 -11,622,000 -12,455,000 -12,495,000 -16,494,000 -18,304,000 -15,790,000 -15,618,000 -19,158,000 -17,071,000 -17,771,000 -19,239,000 -18,128,000 -20,771,000 -17,071,000 -18,508,000 -17,952,000
Net Income -9,796,000 -9,436,000 -8,624,000 -26,808,000 -10,976,000 -11,603,000 -11,540,000 -15,404,000 -17,107,000 -14,467,000 -14,301,000 -17,859,000 -16,096,000 -17,300,000 -18,911,000 -17,920,000 -20,602,000 -16,939,000 -17,930,000 -17,987,000
Cash From Operations -13,363,000 -7,638,000 -6,268,000 -22,713,000 -12,994,000 -6,969,000 -11,454,000 -9,776,000 -12,606,000 -10,670,000 -12,778,000 -14,747,000 -14,779,000 -8,949,000 -15,001,000 -14,489,000 -15,447,000 -13,449,000 -12,662,000 -17,222,000
Capex n/a n/a n/a n/a n/a 34,000 -170,000 -301,000 -37,000 -13,000 -279,000 -280,000 -248,000 -865,000 -532,000 -414,000 -305,000 -825,000 -556,000 -213,000
Free Cash Flow n/a n/a n/a n/a n/a -6,935,000 -11,624,000 -10,077,000 -12,643,000 -10,683,000 -13,057,000 -15,027,000 -15,027,000 -9,814,000 -15,533,000 -14,903,000 -15,752,000 -14,274,000 -13,218,000 -17,435,000
Cash And Equivalents 15,167,000 25,982,000 7,324,000 4,892,000 21,827,000 27,727,000 27,702,000 20,848,000 18,358,000 13,082,000 19,519,000 22,019,000 29,973,000 26,630,000 31,050,000 28,163,000 10,652,000 12,337,000 36,664,000 34,903,000
Total Current Assets 31,741,000 43,747,000 32,640,000 40,015,000 58,897,000 71,807,000 78,693,000 90,455,000 102,552,000 112,725,000 122,684,000 135,299,000 148,918,000 163,983,000 175,315,000 192,954,000 208,933,000 227,817,000 243,036,000 258,632,000
Total Liabilities 11,261,000 15,240,000 15,967,000 16,043,000 11,282,000 15,388,000 14,753,000 17,148,000 16,111,000 13,617,000 13,487,000 14,950,000 13,588,000 16,631,000 8,368,000 8,174,000 8,810,000 9,000,000 9,599,000 11,761,000
Shares Outstanding 3,607,555 3,505,621 2,676,110 2,337,516 28,006,684 28,006,684 27,975,840 27,975,840 27,903,627 27,903,027 27,839,968 27,839,968 27,774,536 27,774,536 27,748,844 27,748,844 27,725,162 27,680,997 27,619,763 27,611,555
Shares Outstanding Diluted n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Weighted Avg Shares Diluted 5,239,236 2,842,448 2,676,116 2,374,729 28,006,684 27,964,639 27,975,840 27,972,744 27,903,040 27,836,584 27,839,968 27,828,741 27,774,536 27,744,209 27,748,844 27,744,762 27,708,768 27,615,977 27,615,038 27,610,398
Weighted Avg Shares Basic 5,239,236 2,842,448 2,676,116 2,374,729 28,006,684 27,964,639 27,975,840 27,972,744 27,903,040 27,836,584 27,839,968 27,828,741 27,774,536 27,744,209 27,748,844 27,744,762 27,708,768 27,615,977 27,615,038 27,610,398
Audit Trail

NCAV Audit

Official-source inputs remain linked to filing provenance. Derived values are labeled as such.

Input Value Source concept Filing period Confidence Provenance
Current Assets 31,741,000USD us-gaap:AssetsCurrent 2026-03-31 1.00 sec/companyfacts/cik=0001661059/companyfacts.json
D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001661059\companyfacts.json
Total Liabilities 11,261,000USD us-gaap:Liabilities 2026-03-31 1.00 sec/companyfacts/cik=0001661059/companyfacts.json
D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001661059\companyfacts.json
Cash 15,167,000USD us-gaap:CashAndCashEquivalentsAtCarryingValue 2026-03-31 1.00 sec/companyfacts/cik=0001661059/companyfacts.json
D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001661059\companyfacts.json
Shares Outstanding 3,607,555 us-gaap:CommonStockSharesOutstanding 2026-03-31 1.00 sec/companyfacts/cik=0001661059/companyfacts.json
D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001661059\companyfacts.json
NCAV 20,480,000USD derived 2026-03-31 n/a company-evidence-v1 | total_current_assets - total_liabilities
NCAV per share 5.68USD derived 2026-03-31 n/a company-evidence-v1 | NCAV / shares_outstanding
Margin of Safety 66.9% derived 2026-03-31 n/a gnni_publication_pack | internal_discount

NCAV = total_current_assets - total_liabilities | NCAV per share = NCAV / shares_outstanding

Source Provenance

Data Source
Data Vault
Data Vault Root
D:\Projects\The Data Vault
CIK
0001661059
Company ID
n/a
Selected Annual Source
D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001661059\companyfacts.json
Selected Quarterly Source
D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001661059\companyfacts.json
Statement Extractor
companyfacts-screener-v1
View Extractor
companyfacts-screener-v1
Source Accession Count
23
Imported At
2026-07-04T23:04:35+00:00
Rendered At
2026-07-05T09:06:29+00:00

Run Audit

Mary Run
1ec055d81d1a42a39490a83bb9e1f22f
Mary As Of
2026-07-03
Accession
0001104659-26-057187
CIK
0001661059
Mary Filing Date
2026-05-07
Filing Currency
USD
Internal Discount
66.9%
Source State
Verified
Market Context
Not Displayed
Market Policy
internal_only_not_redistributed
Share Trend
Not Evaluated
Dilution
Needs Review

mary_run=1ec055d81d1a42a39490a83bb9e1f22f; mary_as_of=2026-07-03; mary_filing_date=2026-05-07; mary_accession=0001104659-26-057187; mary_cik=0001661059; gnni_supporting_filing_date=2026-05-07; internal_discount=0.668838; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.

Back to Register Archive